Duncan Williams Asset Management »

Cara Therapeutics shares owned by Duncan Williams Asset Management

Quarter-by-quarter ownership of Cara Therapeutics (CARA) shares owned by Duncan Williams Asset Management from 13F filings

Historical chart of Duncan Williams Asset Management investment in Cara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cara Therapeutics held by Duncan Williams Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cara Therapeutics by Duncan Williams Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $859k 22k 38.97
2025-06-30 $509k 22k 23.33

More positions owned by Duncan Williams Asset Management

Vanguard Growth Etf Etf (VUG)
Wisdomtree Us Quality Dividend Growth Fund Etf (DGRW)
Ishares Core S&p Us Value Etf Etf (IUSV)
Apple Stock (AAPL)
Schwab Us Dividend Equity Etf Etf (SCHD)
Tr Activebeta Us Small Cap Equity Etf Etf (GSSC)
Vanguard S&p 500 Etf Etf (VOO)
Microsoft Stock (MSFT)
Vanguard Value Etf Etf (VTV)
First Horizon Corporation Stock (FHN)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Powershares Qqq Tr Etf (QQQ)
Vanguard Small-cap Etf Etf (VB)
Vanguard Ftse Emerging Markets Etf Etf (VWO)

View all positions for Duncan Williams Asset Management

Top funds holding Cara Therapeutics

Duncan Williams Asset Management
LRI Investments
Cornerstone Planning Group
Creative Financial Designs
Painted Porch Advisors
Farther Finance Advisors
Sound Income Strategies
Front Row Advisors

View all funds holding Cara Therapeutics